Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures

Ankle Fractures Clinical Trial

Official title:

Six Weeks Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B/SER4a Ankle Fractures - a Multicenter Randomized Non-inferiority Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05412693
• Other study ID #: 22/00257-3
• Status: Recruiting
• Phase: N/A
• Start date: May 15, 2022
• Est. completion date: December 31, 2025

Study information

• Verified date: January 2023
• Source: Ostfold Hospital Trust
• Contact: Martin Gregersen
• Phone: 48171718
• Email: martinggregersen[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Stability dictates treatment choice for trans-syndesmotic fibula fractures. Optimal treatment for partially unstable fractures remains a topic of debate. The purpose of this study is to evaluate possible outcome non-inferior of functional orthosis treatment versus cast immobilization for these fractures.

Description:

Evidence suggests that Weber B ankle fractures should be treated nonoperatively if the ankle mortise is stable. Stability is maintained if the deltoid ligament is intact, also known as a Weber B/SER2 injury. Functional orthosis treatment is advised for these injuries. Recently, authors have demonstrated that the fractured ankle can be functionally stable even with a partial deltoid ligament injury. Our interpretation of a partial deltoid ligament injury is when weightbearing radiographs indicate stability (no increase in medial clear space), while concomitant gravity stress radiographs indicate instability (due to increase in medial clear space). It is suggested that this is referred to as a Weber B/SER4a injury. Although now considered for nonoperative treatment, partially unstable/SER4a injuries were traditionally treated operatively. Today, the superiority of one method of nonoperative treatment over another for partially unstable/SER4a injuries remains unclear. Some authors advocate cast immobilization while others have shown good outcomes after inconsistently using different orthoses and cast devices. The argument for cast immobilization appears to be a fear of posttraumatic osteoarthritis because of potential recurrent instability. As a result, cast immobilization of partially unstable/SER4a fractures is implemented in reference European guidelines, and thus must be considered the reference treatment. To our knowledge, no study has documented increased prevalence of osteoarthritis associated with functional treatment of partially unstable/SER4a fractures. The use of cast immobilization remains a precautionary principle, but the choice is not so clear cut because cast immobilization comes with an increased risk of joint stiffness and thromboembolic complications. Long-term radiographic and patient-reported outcome data evaluating possible non-inferiority of functional orthosis treatment compared to cast immobilization will assist in guiding future treatment strategies of these common fractures.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 110
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients:

• With isolated Weber type B fractures that are deemed stable on weightbearing radiographs (MCS injured ankle - MCS uninjured ankle < 1 mm).

• With concomitant gravity stress test evaluated as unstable (MCS injured ankle - MCS uninjured ankle < 1 mm)

• Presenting to one of the participating hospitals, and that are available for stability evaluation within 14 days after injury.

• 18-80 years of age

• With pre-injury walking ability without aids.

Exclusion Criteria:

• Patients:

• with fracture of the medial malleolus, pre-hospital closed fracture reduction, open fracture, fracture resulting from high-energy trauma or multi-trauma or pathologic fracture.

• with fracture of the posterior malleolus involving 25% or more of the joint surface or with a step of the intraarticular surface. (non-displaced fractures smaller than 25% can be included)

• with neuropathies and generalized joint disease such as Rheumatoid Arthritis.

• that are assumed not compliant (drug use, cognitive- and/or psychiatric disorders).

• with previous history of ipsilateral ankle fracture.

• with previous history of ipsilateral major ankle-/foot surgery.

• who live outside one of the participating hospitals catchment areas (not available for follow-up).

Related Conditions & MeSH terms

• Ankle Fractures
• Fractures, Bone

Intervention

Device:
• Functional orthosis
See arm descriptions
• Cast immobilization
See arm descriptions

Locations

Country	Name	City	State
Norway	Ålesund Hospital	Ålesund
Norway	Sykehuset Innlandet, Gjøvik	Gjøvik
Norway	Østfold Hospital Trust	Sarpsborg	Østfold

Sponsors (3)

Lead Sponsor	Collaborator
Ostfold Hospital Trust	Alesund Hospital, Sykehuset Innlandet HF

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from 6 weeks Manchester-Oxford Foot and Ankle Questionnaire score at 2 years	Scale 0-100, lower scores indicate less pain and symptoms.	6 weeks, 2 years
Secondary	Change from 6 weeks Olerud Molander Ankle Score at 2 years	Scale 0-100, higher scores indicate less pain and symptoms.	6 weeks, 2 years
Secondary	Numeric rating scale of of patient satisfaction with treatment protocol	A 0-10 rating scale for perceived satisfaction with orthosis or cast	6 weeks
Secondary	Change from baseline tibiotalar congruity at 2 years	Measurement of ankle medial clear space from weightbearing and gravity stress ankle radiographs	Baseline, 2 years
Secondary	Registrations of complications/adverse events	Registration of possible loss of congruence, delayed union, non-union, thromboembolic events	2 years
Secondary	Change from 6 weeks ankle range of motion at 2 years	Measurement using a goniometer (ad modum Lindsjø)	6 weeks, 2 years